Evidence map›Paper›PMID 38827142›Full record

ArticleCanadian journal of kidney health and disease2024

Association Between the Dialysate Bicarbonate and the Pre-dialysis Serum Bicarbonate Concentration in Maintenance Hemodialysis: A Retrospective Cohort Study.

Amber O Molnar, Lauren Killin, Sarah Bota, Eric McArthur, Stephanie N Dixon, Amit X Garg, Claire Harris, Stephanie Thompson, Karthik Tennankore, Peter G Blake and 3 more

Abstract read
In one paragraph

Article in Canadian journal of kidney health and disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amber O MolnarDivision of Nephrology, Department of Medicine, McMaster University, Hamilton, ON, Canada.ORCID https://orcid.org/0000-0003-4549-0202
Lauren KillinInstitute for Clinical Evaluative Sciences, London, ON, Canada.
Sarah BotaInstitute for Clinical Evaluative Sciences, London, ON, Canada.
Eric McArthurInstitute for Clinical Evaluative Sciences, London, ON, Canada.ORCID https://orcid.org/0009-0000-6944-6471
Stephanie N DixonInstitute for Clinical Evaluative Sciences, London, ON, Canada.ORCID https://orcid.org/0000-0002-7566-6574
Amit X GargInstitute for Clinical Evaluative Sciences, London, ON, Canada.ORCID https://orcid.org/0000-0003-3398-3114
Claire HarrisDivision of Nephrology, Department of Medicine, The University of British Columbia, Vancouver, Canada.
Stephanie ThompsonDivision of Nephrology, Department of Medicine, University of Alberta, Edmonton, Canada.ORCID https://orcid.org/0000-0003-3109-6837
Karthik TennankoreDivision of Nephrology, Department of Medicine, Nova Scotia Health Authority, Halifax, Canada.
Peter G BlakeDivision of Nephrology, Department of Medicine, Western University, London, ON, Canada.
Clara BohmDivision of Nephrology, Department of Medicine, University of Manitoba, Winnipeg, Canada.
Jennifer MacRaeDivision of Nephrology, Department of Medicine, University of Calgary, AB, Canada.
Samuel A SilverInstitute for Clinical Evaluative Sciences, London, ON, Canada.ORCID https://orcid.org/0000-0002-1843-6131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It is unclear whether the use of higher dialysate bicarbonate concentrations is associated with clinically relevant changes in the pre-dialysis serum bicarbonate concentration. Objective: The objective is to examine the association between the dialysate bicarbonate prescription and the pre-dialysis serum bicarbonate concentration. Design: This is a retrospective cohort study. Setting: The study was performed using linked administrative health care databases in Ontario, Canada. Patients: Prevalent adults receiving maintenance in-center hemodialysis as of April 1, 2020 (n = 5414) were included. Measurements: Patients were grouped into the following dialysate bicarbonate categories at the dialysis center-level: individualized (adjustment based on pre-dialysis serum bicarbonate concentration) or standardized (>90% of patients received the same dialysate bicarbonate concentration). The standardized category was stratified by concentration: 35, 36 to 37, and ≥38 mmol/L. The primary outcome was the mean outpatient pre-dialysis serum bicarbonate concentration at the patient level. Methods: We examined the association between dialysate bicarbonate category and pre-dialysis serum bicarbonate using an adjusted linear mixed model. Results: All dialysate bicarbonate categories had a mean pre-dialysis serum bicarbonate concentration within the normal range. In the individualized category, 91% achieved a pre-dialysis serum bicarbonate ≥22 mmol/L, compared to 87% in the standardized category. Patients in the standardized category tended to have a serum bicarbonate that was 0.25 (95% confidence interval [CI] = -0.93, 0.43) mmol/L lower than patients in the individualized category. Relative to patients in the 35 mmol/L category, patients in the 36 to 37 and ≥38 mmol/L categories tended to have a serum bicarbonate that was 0.70 (95% CI = -0.30, 1.70) mmol/L and 0.87 (95% CI = 0.14, 1.60) mmol/L higher, respectively. There was no effect modification by age, sex, or history of chronic lung disease. Limitations: We could not directly confirm that all laboratory measurements were pre-dialysis. Data on prescribed dialysate bicarbonate concentrations for individual dialysis sessions were not available, which may have led to some misclassification, and adherence to a practice of individualization could not be measured. Residual confounding is possible. Conclusions: We found no significant difference in the pre-dialysis serum bicarbonate concentration irrespective of whether an individualized or standardized dialysate bicarbonate was used. Dialysate bicarbonate concentrations ≥38 mmol/L (vs 35 mmol/L) may increase the pre-dialysis serum bicarbonate concentration by 0.9 mmol/L.

Indexed as

dialysishemodialysismetabolic acidosis

Identifiers

PMID38827142
PMCPMC11141227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.